Screener
Olema Pharmaceuticals, Inc. OLMA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $52,547 | $48,301 |
| Marketable securities | 452,800 | 457,136 |
| Prepaid expenses and other current assets | 7,882 | 10,015 |
| Total current assets | 513,229 | 515,452 |
| Operating lease right-of-use assets | 921 | 1,146 |
| Other assets and long-term deposits | 16,495 | 16,832 |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s short-term investments?
- Olema Pharmaceuticals, Inc. (OLMA) reported short-term investments of $452.8M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Olema Pharmaceuticals, Inc.'s short-term investments increased by 32.4% year-over-year, from $342.07M to $452.8M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s short-term investments has grown at a 13.7% compound annual growth rate (CAGR), from $273.44M to $457.14M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Olema Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude